Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
176,565,779
-
Share change
-
+1,541,749
-
Total reported value
-
$19,299,757,559
-
Put/Call ratio
-
108%
-
Price per share
-
$109.31
-
Number of holders
-
733
-
Value change
-
+$155,016,794
-
Number of buys
-
342
-
Number of sells
-
311
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2017
As of 30 Sep 2017,
Edwards Lifesciences Corp - Common Stock (EW) was held by
733 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
176,565,779 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., Bank of New York Mellon Corp, AMERIPRISE FINANCIAL INC, BROWN ADVISORY INC, and NORGES BANK.
This page lists
736
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.